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http://dx.doi.org/10.1016/j.pedneo.2
1875-9572/Copyrightª 2016, Taiwan P
NC-ND license (http://creativecommoThe goal of modern neonatal care of extremely preterm infants is to reduce mortality and long-
term neurological impairments. Preterm infants frequently experience cerebral intraventric-
ular or pulmonary hemorrhage, which usually occurs within 72 hours after birth and can lead
to long-term neurological sequelae and mortality. These serious hemorrhagic complications
are closely related to perinatal hemodynamic changes, including an increase in the afterload
on the left ventricle of the heart after the infant is separated from the placenta, and an
increased preload from a left-to-right shunt caused by a hemodynamically significant patent
ductus arteriosus (PDA). The left ventricle of a preterm myocardium has limited ability to
respond to such an increase in afterload and preload, and this can result in cardiac dysfunction
and hemodynamic deterioration. We suggest that delayed umbilical cord clamping or umbilical
cord milking to maintain optimal blood pressure and systemic blood flow (SBF), careful assess-
ment to keep the afterload at an acceptable level, and a strategy of early targeted treatment
of significant PDA to improve perfusion during this critical time period may reduce or prevent
these serious complications in preterm infants.
Copyright ª 2016, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).1. Introduction
Preterm infants undergo a perinatal transition from fetal to
postnatal circulation that causes significant hemodynamicof Neonatology, China Medical Un
om (B.-H. Su).
016.01.001
ediatric Association. Published by
ns.org/licenses/by-nc-nd/4.0/).stress on the cardiovascular system, especially in preterm
infants with premature myocardial function. The major
cause of this hemodynamic stress is interruption of the
placental circulation at birth. The placental circulation is aiversity Children’s Hospital, 2 Yuh-Der Road, Taichung, 404, Taiwan.
Elsevier Taiwan LLC. This is an open access article under the CC BY-
454 B.-H. Su et allow resistance, highly compliant vascular bed that receives
a large proportion (30e50%) of total cardiac output.1 Sud-
den interruption of the placental circulation results in an
abrupt increase in resistance in the systemic arteries, and
thus in an increase in the afterload on the left ventricle of
the heart.2e5 In addition, the left ventricle may also face
increased preload from a left-to-right shunt caused by a
hemodynamically significant patent ductus arteriosus
(PDA).6,7
The immature myocardium in premature infants has
limited ability to respond to such an increase in afterload
and change in preload. Some infants may experience
serious hemorrhagic complications such as cerebral intra-
ventricular hemorrhage (IVH) or pulmonary hemorrhage,
which usually occurs within 72 hours after birth and can
affect the long-term neurological development of prema-
ture infants and even cause mortality.
The goal of modern neonatal care of extremely preterm
infants is to reduce mortality and neurological impair-
ments. Without understanding the underlying cardiovascu-
lar mechanism of transition, appropriate interventional
management strategies cannot be implemented. As the
serious hemorrhagic complications are closely related to
perinatal hemodynamic changes, we focused on the clinical
perspective of circulatory management to prevent IVH or
pulmonary hemorrhage in preterm infants in this review.2. Delayed umbilical cord clamping versus
umbilical cord milking in preterm infants2.1. Delayed cord clamping
Delayed cord clamping (DCC) by 30e120 seconds rather
than immediate clamping has been reported to be associ-
ated with less need for transfusion and lower rate of IVH.8
In December 2012, the American College of Obstetricians
and Gynecologists recommended a delay of 30e60 seconds
in umbilical cord clamping for all preterm deliveries.9
Although DCC has been shown to decrease the overall
incidence of IVH, it has not been shown to have a beneficial
effect on severe IVH, and thus its clinical application has
been limited.102.2. Umbilical cord milking
The lack of a beneficial effect of DCC on severe IVH may
reflect a lack of adequate placental transfusion during DCC
for infants delivered by cesarean delivery.11e13 An alter-
native to DCC is umbilical cord milking (UCM), a procedure
that can be performed in 20 seconds.14 UCM is performed by
holding the infant at or 20 cm below the level of the
placenta. The cord is pinched as close to the placenta as
possible and milked toward the infant for 2 seconds. The
cord is then released and allowed to refill with blood for
1e2 seconds between each milking motion. This is repeated
a total of four times. After completion, the cord is clamped
and the neonate handed to the resuscitation team. Milking
the cord four times provides a similar amount of placental-
fetal blood compared with DCC for 30 seconds.15A recent meta-analysis of UCM including seven random-
ized clinical trials involving 501 infants delivered at <
33 weeks, demonstrated that infants who underwent UCM
had a higher hemoglobin level and lower risk of oxygen
requirement at 36 weeks and IVH of all grades compared
with those who underwent immediate cord clamping.16
2.3. Comparison between UCM and DCC
Most preterm infants are delivered by cesarean section,
and a placental blood transfusion may be less effective in a
cesarean delivery than in a vaginal delivery. A recent study
which enrolled 197 infants (mean gestational age
28  2 weeks) reported a higher hemoglobin level at birth,
improved hemodynamics (higher blood flow and improved
blood pressure), and improved urine output with UCM
compared with DCC in preterm infants delivered by cesar-
ean section.17 The authors also noted superior venous cava
(SVC) flow and higher right ventricular output in infants
treated with UCM. SVC flow represents cardiac input, and is
therefore a useful measure of systemic blood flow (SBF) in
the newborn heart and an important marker of neonatal
transition.18,19 Previous reports have demonstrated that
lower right ventricular output is closely associated with
worsening respiratory disease, severe IVH, and death.20 A
higher overall SBF is probably related to an increased blood
volume from a placental transfusion resulting in improved
hemodynamics. Infants undergoing UCM have also been
reported to have higher urine output and blood pressure,
suggesting that these infants have some improvements in
organ perfusion within the first 24 hours of life.17 Improved
perfusion during this critical time period may prevent IVH
by stabilizing fluctuations in SBF.18 There were fewer neo-
nates with total and severe IVH in the UCM group, which is
consistent with Rabe et al15 who compared UCM and DCC.
An additional advantage of UCM is the short procedure
time. This not only allows for a minimal delay in resusci-
tation, but also reduces the amount of time the newborn is
exposed to a lower temperature.17 A recent pilot study of
75 extremely premature neonates (born at a gestational
age < 29 weeks) randomly assigned to receive UCM or im-
mediate cord clamping demonstrated a 50% reduction in
total IVH.21 In another recent retrospective study of UCM in
318 infants born at < 30 weeks, UCM was associated with
reductions in IVH, necrotizing enterocolitis, and death
before hospital discharge.22 The authors further suggested
that UCM may be more beneficial for smaller, more imma-
ture neonates.21,22
Taken together, UCM provides a greater placental
transfusion, as demonstrated by higher initial Hb level,
higher blood pressure, and improved SBF and urine output
in infants delivered by cesarean delivery. UCM may thus be
preferable in preterm infants delivered by cesarean de-
livery, particularly when immediate resuscitation is
needed.17
2.4. Concerns over UCM and DCC
Concerns have been raised over UCM as to whether it can
provide a rapid bolus of blood. Rapid changes in venous
pressure during UCM were addressed in an early trial that
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UCM compared with uterine contractions or a newborn cry
during intact placental circulation.23 With UCM, placental
blood is directed towards the lungs during a time when
there is a rapid fall in pulmonary resistance unlike any
other period when volume is given.17,23 A recent meta-
analysis evaluating the safety and efficacy of UCM at birth
concluded that there was a lower risk of oxygen require-
ment at 36 weeks and IVH of all grades.16 Therefore, we
suggest that UCM should no longer be considered as
experimental, but rather as a proven intervention which
can ensure that premature newborns receive an adequate
placental transfusion at birth.
The potential for developing hyperbilirubinemia is
another issue of concern. A Cochrane review found that
none of the neonates with elevated bilirubin levels required
phototherapy treatment or exchange transfusions.8 How-
ever, in populations more susceptible to neonatal hyper-
bilirubinemia, and especially those of Asian ethnicity,
careful monitoring of the serum bilirubin level is
warranted.2.5. The recommendations of the Umbilical Cord
Management in the International Liaison
Committee on Resuscitation for the Neonatal
Resuscitation Program
According to the 2010 International Consensus on Cardio-
pulmonary Resuscitation and Emergency Cardiovascular
Care Science With Treatment Recommendations24 and
subsequent review of DCC and cord milking in preterm
newborns in the 2015 Umbilical Cord Management in the
International Liaison Committee on Resuscitation (ILCOR)
systematic review,25,26 DCC for longer than 30 seconds is
reasonable for both term and preterm infants who do not
require resuscitation at birth. However, there is insufficient
evidence to recommend cord clamping for infants who
require resuscitation at birth, and more randomized trials
involving such infants are needed.
In light of the limited information regarding the safety of
rapid changes in blood volume for extremely preterm in-
fants, the ILCOR suggest that cord milking should not be
routinely used for infants born at < 29 weeks of gestation
outside of a research setting. Further studies are warranted
to elucidate this issue, because cord milking may improve
the initial mean blood pressure, hematologic indices, and
reduce intracranial hemorrhage. However, there is
currently no evidence with regards to improvements in
long-term outcomes.
After the 2015 ILCOR systematic review, several
studies16,17,22 reported that UCM was associated with some
benefits and no adverse effects in the immediate postnatal
period in preterm infants (see Sections 2.2 and 2.3). It is
possible that UCM may be more beneficial for smaller, more
immature neonates who require resuscitation at birth;21,22
however, further studies are warranted to assess the ef-
fect of UCM on neonatal and long-term outcomes.
Another recent randomized controlled trial reported the
effects of placental transfusion on neonatal and 18-month
outcomes in preterm infants.27 For those receiving DCC, the
obstetrician placed the infant in a sterile, warm towel orblanket and held them approximately 10e15 inches below
the mother’s introitus in a vaginal delivery, or below the
level of the placenta in a cesarean delivery. Suctioning was
performed at the discretion of the obstetrician. At
30e45 seconds, the obstetrician milked the infant’s cord
once, then clamped and cut the umbilical cord. If the DCC
protocol could not be performed as planned, the cord was
milked quickly two to three times before clamping when
possible. The immediate cord clamping group received
routine care of cord clamping in less than 10 seconds.
Pregnant women in labor with singleton fetuses (n Z 208)
between 24 weeks of gestation and 31.6 weeks of gestation
were enrolled. Infants in the DCC and immediate cord
clamping groups weighed 1203  352 g and 1136  350 g,
respectively, with a mean gestational age of 28.3  2 weeks
and 28.4  2 weeks, respectively. There were no differ-
ences in the number of infants who received phototherapy,
days of phototherapy, delivery room resuscitation,
Neonatal Acute Physiology scores at 12 hours of age, and
the rates of IVH or late onset sepsis between the groups. In
addition, at 18e22 months, DCC was found to be protective
against motor scores < 85 on the Bayley Scales of Infant
Development, Third Edition. The authors concluded that
although DCC did not alter the incidence of IVH or late
onset sepsis in preterm infants, it improved motor function
at 18e22 months corrected age.
3. Optimal blood pressure in preterm infants
3.1. Definition of hypotension in preterm infants
Hypotension is a commonly diagnosed and treated compli-
cation in preterm infants. It is defined as any blood pressure
value that falls below the fifth or 10th percentile for
gestational and postnatal age, respectively.28 Although the
lower limits of normal blood pressure for gestational and
postnatal age in extremely preterm infants are not known,
many neonatologists routinely treat infants whose mean
arterial blood pressure is less than their gestational age in
weeks.28e31 Treatment typically consists of volume in-
fusions, followed by inotrope infusions, and predominantly
dopamine.29,32 If the initial inotrope therapy fails, dobut-
amine is the most popular second-line therapy.33 There is
also a growing trend in the use of hydrocortisone therapy in
hypotensive very low birth weight infants.34,35
3.2. Blood pressure and SBF
In preterm infants during the first days of life, there is a
poor association between blood pressure and SBF.36,37 Low
SVC flow, a useful measure of SBF, is a known risk factor for
mortality and morbidity in preterm infants, however hy-
potension itself is not reliable in detecting low SBF.18,19 The
principal role of the circulation is to ensure adequate de-
livery of oxygen and nutrients to tissues, and this is ach-
ieved by maintaining appropriate perfusion pressure and
cardiac output in the systemic and pulmonary circula-
tions.37 Preterm infants with a mean arterial blood pressure
lower than their gestational age in weeks often have no
clinical signs of shock and presumably have adequate tissue
oxygen delivery, and may therefore not need treatment.30
Table 1 Global assessment of cardiovascular status
including clinical signs, biochemical data and echocardio-
graphic evaluation.*
Clinical signs Refilling time, skin color,
heart rate, mean blood pressure,
urine output, activity
Biochemical
examinations
Lactic acid, base excess, B-type
natriuretic peptide
456 B.-H. Su et alThere is no evidence that attempts to achieve a
“normal” blood pressure based on arbitrary guideline
values but with clinical evidence of good perfusion will
improve outcomes, and the currently available therapies
may be toxic or dangerous.38 Dopamine may increase blood
pressure at the expense of systemic perfusion in certain
patients (see Section 4.2), and particularly at high doses.39
Therefore, the drug should be carefully titrated to achieve
an “optimal” blood pressure response to successfully
increase blood pressure and SBF at low-to-moderate
doses.40
We suggest that the best approach is to continuously
monitor both blood pressure and SBF in these patients.
Continuous arterial blood pressure monitoring using an
indwelling catheter is considered to be the gold standard of
measuring blood pressure in critically ill neonates.41,42
Although blood pressure is also frequently measured non-
invasively, it is less accurate (especially in severe hypo-
tension, and with overestimation of hypotension and
underestimation of hypertension). Most importantly,
noninvasive measurements of blood pressure are not
continuous and cannot provide reliable values of mean or
diastolic blood pressure, although they can be used for
trends in changes of blood pressure. In addition, various
cuff sizes are needed, because if the cuff is too small the
blood pressure will be overestimated.
The currently available tools to assess SBF in very low
birth weight neonates at the bedside, such as near infrared
spectroscopic topography, ultrasonic cardiac output
monitor (USCOM), and electrical velocimetry have signifi-
cant limitations and are primarily used for research
purposes.30,42e47 Based on the overall poor correlation
between USCOM and invasive cardiac output measurement
studies, the use of USCOM should be restricted to
well-defined clinical trials before this noninvasive
modality of monitoring cardiac output can be considered
for routine use in preterm infants. In the future,
USCOM may serve as a feasible and fast diagnostic tool to
measure changes in cardiac output in response to
treatment (such as vasopressor therapy and fluid
challenge).Echocardiography Left ventricular (LV) systolic function
Ejection fraction
Fractional shortening
Stress-velocity relationship
(a relatively load-independent
cardiac function index)59
End-systolic wall stress (an index
of LV afterload)
LV rate-corrected mean
velocity of circumferential fiber
shortening (mVcfc, an index of
LV pump function)
Patent ductus arteriosus assessment
Pulsed Doppler flow patterns52,53
and color Doppler ductal diameter78
left atrium/aorta
Cardiac output : superior vena
cava flow (a useful measure of
systemic blood flow)19
* Summarized from Dempsey et al30 and Toyoshima et al39.3.3. Global assessment of cardiovascular status
The global assessment of cardiovascular status (Table 1)
includes assessments of easily evaluable physical observa-
tions such as capillary refill, skin color, heart rate, mean
blood pressure, urine output, level of activity, and
biochemical examinations, and in particular, the degree of
acidosis.28,30 Laboratory indices of perfusion such as serum
lactate and acidosis (base excess) during anaerobic meta-
bolism are frequently used in the diagnosis of poor tissue
perfusion.48 Correlations between lactate values with SBF
have been shown to be improved by combining capillary
filling time, lactate > 4 mmol/L plus a prolonged capillary
refill time > 4 seconds, and have been shown to have a high
positive predictive value (80%) and negative predictive
value (88%) for identifying low SVC flow. This highlights
the importance of combining clinical and biochemical
data when assessing the adequacy of end-organ blood
flow.19,373.4. Permissive hypotension
Dempsey et al30 evaluated this approach (global assessment
of cardiovascular status) in extremely low birth weight in-
fants in the first 72 hours of life, and grouped the patients
as either normotensive (blood pressure never less than
gestational age), hypotensive untreated (blood pressure
less than gestational age but with signs of good perfusion;
termed as “permissive hypotension”), or hypotensive
treated (blood pressure less than gestational age with signs
of poor perfusion). Blood pressure was found to spontane-
ously improve in the extremely low birth weight infants
during the first 24 hours, and the outcomes of the
hypotensive infants using the gestational age criteria
but with clinical evidence of good perfusion were as good as
those of normotensive patients. Therefore, global assess-
ments of cardiovascular status and interventions for
hypotension restricted to infants with poor perfusion
(skin color, capillary refill rate, urine output, blood lactate
level, and acidosis) may result in good clinical
outcomes.30,49
4. Hemodynamic evaluation of preterm infants
by echocardiography
4.1. Hemodynamic changes in preterm infants
It is well known that the perinatal transition from the fetal
to the postnatal circulation causes dramatic loading
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of the left ventricle faces a high afterload
after the neonate is separated from the placenta.2e5 In
addition, the left ventricle may also face increased preload
from a left-to-right shunt caused by a hemodynamically
significant PDA.6,7,50 However, the preterm left
ventricle has a limited ability to respond to such an
increased afterload and change in preload. This results in
depressed cardiac function and deterioration in
hemodynamics.Figure 1 Stress-velocity relationship (mVcfc-ESWS relation-
ship).59 There were significant correlations between ESWS (an
index of LV afterload) and mVcfc (an index of LV pump func-
tion) in both groups (mVcfc Z 3.76  ESWS-0.4; p < 0.01,
R Z 0.56). Group 1: infants with complications (pulmonary
hemorrhage, intraventricular hemorrhage, and periventricular
leukomalacia; n Z 9). Group 2: infants without complications
(n Z 24). Systolic blood pressure (sBP) and mean blood pres-
sure (mBP) changed over time, with no differences between
the groups. ESWS, end-systolic wall stress; LVZ left ventricle;
mVcfc Z mean velocity of circumferential fiber shortening.
Note. From “Tailor-made circulatory management based on
the stress-velocity relationship in preterm infants,” by K.
Toyoshima, M. Kawataki, M. Ohyama, J. Shibasaki, N. Yama-
guchi, R. Hoshino, et al, 2013, J Formos Med Assoc, 112, p.
510e7. Copyright 2013, Elsevier Taiwan LLC & Formosan
Medical Association. Adapted with permission.4.2. Stress-velocity relationship: a sensitive
echocardiographic index for evaluation of cardiac
function
In addition to the global assessment of cardiovascular sta-
tus described above, functional echocardiography per-
formed by a neonatologist is also frequently used to
evaluate and delineate the nature of hemodynamic insta-
bility, the significance of a PDA, and the presence or
severity of pulmonary hypertension.51e58 The LV ejection
fraction and fractional shortening are commonly used to
estimate LV systolic function, however both are largely
influenced by preload, afterload, and heart rate.59
The stress-velocity relationship is a relatively load-
independent index which has been used to effectively
evaluate cardiac function in preterm infants.3e5,50,59,60 This
index is calculated from the end-systolic wall stress (ESWS,
an index of left ventricle afterload), and the left ventricle
rate-corrected mean velocity of circumferential fiber
shortening (mVcfc, an index of left ventricle pump func-
tion). The stress-velocity relationship has been shown to
have a steep slope in the low ESWS range, as illustrated in
Figure 1.39,59 The cardiac pumping function (represented as
mVcfc) is easily impaired, and can be decreased by even a
small increase in afterload (represented as ESWS) in smaller
or younger infants with low ESWS.5,50
Preterm infants frequently have PDA, and concerns have
been raised over its influence on the effectiveness of the
stress-velocity relationship when used in preterm infants.
However, it has been reported that mVcfc and ESWS do not
change after PDA closure,5 which indicates that a PDA does
not affect the measurement of these parameters. Thus, we
suggest that the stress-velocity relationship is a useful
index to evaluate cardiac function in preterm infants in the
early days of life.5. Strategy to prevent IVH and/or pulmonary
hemorrhage
Preterm infants frequently experience IVH or pulmonary
hemorrhage that usually occurs within 72 hours after birth.
The incidence rates of IVH and/or pulmonary hemorrhage
have been reported to be higher in infants with cardiac
dysfunction due to increased afterload.39 According to the
stress-velocity relationship (as described in Section 4.2),
careful evaluation to keep the afterload at an acceptable
level by vasodilator therapy may reduce or prevent these
serious complications.5.1. Germinal matrix: Venous origin of IVH
The subependymal germinal matrix is a fetus-specific
component, and is the most common site of IVH. The
germinal matrix increases in volume until about 26 gesta-
tional weeks and then begins to decrease, disappearing
completely at around 34 weeks.61,62
The vein in the germinal matrix has poor supporting
tissues and a thin vascular wall, and therefore is very sus-
ceptible to bleeding when the venous pressure increases.
When bleeding occurs at the germinal matrix, periven-
tricular veins will be occluded, and this congestion may
extend to the periventricular parenchyma, causing peri-
ventricular hemorrhage (Grade 4 IVH).625.2. Relationship between increased left
ventricular afterload and IVH
Cardiac dysfunction due to an increased afterload, as
indicated by the stress-velocity relationship, has been re-
ported to be associated with IVH in preterm infants.39 To
458 B.-H. Su et alcope with an increased afterload, preload to the heart is
increased through preload reserve.2,63 According to the
ventricular interaction, the increase in left ventricular
preload is very likely to be associated with an increase
in right ventricular preload, that in turn is induced by
an increase in central venous pressure, which then
impedes systemic venous return and leads to an increase in
cerebral venous pressure.63 Finally, the fragile vein in
the germinal matrix cannot tolerate the elevated intra-
cardiac venous pressure, which induces germinal bleeding
and IVH.5.3. Increased LV afterload induces pulmonary
hemorrhage
Cardiac dysfunction due to excessive afterload has
also been associated with pulmonary hemorrhage in
preterm infants.39 Due to the preload reserve described in
Section 5.2, an increased left ventricular afterload
may induce an increase in left ventricular preload, which
may in turn lead to an increase in pulmonary
venous pressure, and finally cause hemorrhagic pulmonary
edema.5.4. Circulatory management based on the stress-
velocity relationship in preterm infants to prevent
IVH and pulmonary hemorrhage
Taken together, venous congestion is associated with IVH
and pulmonary hemorrhage. Therefore, optimal circulatory
management in preterm infants should be attempted to
avoid increases in venous pressure caused by excessive
afterload. Toyoshima et al39 reported the outcomes of using
circulatory management based on the stress-velocity rela-
tionship in preterm infants with a gestational age
of 23 weeks or 24 weeks. This strategy emphasized the use
of catecholamines restricted to infants with a blood
pressure less than their gestational age and associated
with poor perfusion as indicated by an inability to maintain
urine volume, the development of metabolic acidosis, or
continuous increases in lactic acid concentrations.
The authors reported that cardiotonic therapy using
catecholamines was indicated for cardiac pump dysfunction
(ejection fraction < 50% or mVcfc < 0.8 circ/s) at an
ESWS < 40 g/cm2 and that load reduction therapy was
indicated for infants with cardiac pump dysfunction and an
ESWS > 45 g/cm2, or in infants with an ESWS < 45 g/cm2 in
whom there was a trend toward increased ESWS and
decreased ejection fraction and mVcfc. In these infants,
nitroglycerin at a dosage of 0.3 mg/kg/min was started,
and the dosage was increased according to the efficacy.
The authors reported that nitroglycerin treatment reduced
afterload, even at a low dose (0.3e1.5 mg/kg/min), and did
not affect the frequency or efficacy of indomethacin
therapy. They also found that careful management to
control excessive afterload improved morbidity and
mortality in these extremely preterm infants. Furthermore,
the incidence and severity of IVH and the survival rate
improved, with a trend towards a decrease in mental
retardation.6. Management of significant PDA in preterm
infants
6.1. Clinical implication of a significant PDA in
preterm infants
PDA is a major morbidity in preterm infants, especially in
extremely premature infants of < 28 weeks. Persistent PDA
shunting is associated with a range of adverse outcomes
including necrotizing enterocolitis, IVH, pulmonary hem-
orrhage, chronic lung disease, and death.64e68 However,
neither individual trials nor meta-analyses have demon-
strated better long-term neurodevelopmental outcomes
with methods to close a PDA.69,70 Therefore, the debate
over whether or not to close a PDA is ongoing.
The most clinically important question seems to be how
to change a hemodynamically significant PDA into a PDA
that does not compromise the infant’s circulation (either a
decrease in size or fully closed). It is important that the
decision to treat or not treat a PDA is made on a case by
case basis, based on clinical findings and serial echocar-
diographic assessments of hemodynamic status rather than
to depend only on a spot time measurement.53,55e57
The clinical signs and symptoms of PDA in preterm in-
fants are nonspecific and insensitive to allow for an early
diagnosis of significant ductal shunting. Functional echo-
cardiography is emerging as a new valuable bedside tool for
an early diagnosis of hemodynamically significant PDA, and
it has also been used for early targeted treatment of ductus
arteriosus.55,58 Serial echocardiographic assessments can
allow for significantly earlier identification and treatment
of PDA compared to waiting for the evolution of clinical
signs.53,55,58 Severe IVH and the amount of time requiring
ventilator support have been significantly decreased after
the introduction of echocardiography.58 In addition, the use
of biomarkers such as B-type natriuretic peptide and N-
terminal pro B-type natriuretic peptide may be promising
diagnostic tools when assessing the significance of PDA.71,72
The primary mode of treatment for PDA is pharmaco-
logical closure using cyclooxygenase inhibitors, with a
closure rate of 70e80%. Randomized controlled trials of
ibuprofen versus indomethacin in the early targeted
treatment of PDA in preterm infants have shown that
ibuprofen is as effective as indomethacin for the treatment
of PDA without increasing the incidence rates of renal
dysfunction or other complications.55,56,58 Oral ibuprofen is
emerging as a better alternative, especially in countries
where intravenous indomethacin or ibuprofen are unavai-
lable and because there are comparatively fewer side ef-
fects.73 Although pharmacological closure of PDA is an
established treatment modality, there is still a lack of ev-
idence on the long-term benefits of such therapy, although
there is evidence of possible adverse effects such as
increased retinopathy of prematurity and chronic lung dis-
ease rates, especially if treated prophylactically.69
Although prophylactic treatment is the best-studied
regimen, improvements in short-term outcomes do not
seem to improve the rate of survival without neurosensory
impairment at 18 months.74 Observations of very early
postnatal hemodynamically significant PDA in extremely
preterm infants suggest that targeting treatment on the
Circulatory management in preterm infants 459basis of the early postnatal constrictive response of the
duct may be optimal.52,53 Hence, it may be prudent to
reserve treatment of PDA to infants with hemodynamically
significant ductus on the basis of gestation, birth weight,
serial echocardiography, and clinical status, and to make
the decision to treat on a case by case basis.55,58,69,706.2. PDA and pulmonary hemorrhage and IVH
Around 24 hours after birth, pulmonary vascular resistance
decreases and shunt flow through the ductus arteriosus
increases rapidly to induce elevated preload. This condition
has been reported to occur even more frequently in
extremely preterm infants with RDS who receive supple-
mentary surfactant treatment.65e67 The left ventricle of
preterm infants has low distensibility,2,63 and pulmonary
congestion may occur even when it is exposed to a rela-
tively small increase in preload. An increase in left ven-
tricular preload is manifested by an increase in pulmonary
venous pressure and venous congestion, which in turn may
lead to pulmonary hemorrhage. Preterm infants usually
develop pulmonary hemorrhage at a mean age of around
36 hours, at which time they have significantly higher
estimated pulmonary blood flow and significantly larger
ducts, and therefore the clinical impact occurs early in
life.75
It has been reported that ductal shunting is negatively
associated with SBF, and that it occurs very early after birth
during the vulnerable period of circulatory transition.75 A
significant association between early low SBF and the
development of IVH and later necrotizing enterocolitis has
also been noted, suggesting a possible mechanism by which
PDA shunting partially causes these complications.6.3. Early-targeted treatment of significant PDA
Taken together, for PDA treatment to be effective, it has to
be given early after birth. Previous studies have reported
that prophylactic treatment reduces the incidence of sig-
nificant PDA, the need for rescue treatment and surgical
ligation, but unnecessarily exposes a large number of in-
fants to a drug that has important side effects (mainly
affecting the kidneys) without conferring any significant
short-term benefits.74,76
The protocol we use for significant PDA is early targeted
treatment guided by echocardiographic PDA flow pattern
rather than prophylactic prevention of PDA.52,53,55 Preterm
infants are treated as early as within the first 24 hours of
life, and no increase has been found in the incidence of
renal side effects or other severe complications. With this
protocol, the PDA closure rate is around 88%, and the fewer
number of doses (1.9  1.5, mean  standard deviation) of
either ibuprofen or indomethacin may partially explain the
lack of significant renal side effects.55
A recent study of the early treatment of PDA guided by
echocardiographic ductal diameter reported that infants
receiving early indomethacin treatment had a significantly
lower rate of early pulmonary hemorrhage, a nonsignificant
trend towards less IVH, and were less likely to receive later
treatment for PDA.77A strong correlation between early echocardiographic
pulsed Doppler flow patterns and color Doppler ductal
diameter has been noted. Both methods are significantly
associated, and may be used as a cross-check to assist in
the management of preterm infants with PDA. The addition
of flow pattern classification to ductal diameter assess-
ments may further enhance the clinical predictive ability of
echocardiography.56,78 We would like to highlight the
importance of sequential echocardiographic assessments of
the hemodynamic status of PDA rather than to depend only
on spot time measurements.57
6.4. Surgical ligation of PDA
An increased trend of a less aggressive approach to ductal
ligation has been reported, reflecting concerns that ligation
of PDA may do more harm than good.79 A retrospective
comparative study reported the use of a conservative
approach to treat asymptomatic PDA that failed to close
after indomethacin treatment. In this strategy, the pres-
ence of a PDA was tolerable as long as signs of cardiopul-
monary compromise did not develop, and was associated
with a 28% decrease in the rate of ductus ligation with
lower rates of necrotizing enterocolitis compared with
early PDA ligation.79 Several studies have shown acute,
potentially detrimental hemodynamic effects after PDA
ligation,80,81 and in subanalysis of the Trial of Indomethacin
Prophylaxis in Preterms (TIPP), babies who underwent
surgical ligation had worse neurodevelopmental
outcomes.82
Taken together, we suggest that PDA ligation should only
be considered for infants who have echocardiographic evi-
dence of a significant PDA, who have contraindications or
have failed at least two courses of medical treatment, and
who have cardiopulmonary compromise with progressive
oxygen and ventilator demands.
7. Conclusions
Preterm infants frequently experience IVH or pulmonary
hemorrhage, which usually occur within 72 hours after birth
and can lead to long-term neurological impairments and
mortality. As these serious hemorrhagic complications are
closely related to perinatal hemodynamic changes, delayed
umbilical cord clamping or umbilical cord milking to main-
tain optimal blood pressure and SBF, careful assessments to
maintain the afterload at an acceptable level, and a
strategy of early targeted treatment of significant PDA to
improve perfusion during this critical time period may
reduce or prevent these serious complications.
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